Biotricity Announces High Demand For Its LBiotres Pro, a 3-Channel Patch-like ECG, Biotres Pro Is Expected To Raise The Average Subscription Price By Over 32%, Translating To Revenue Increase Of Up To 10% From Sales To Existing Customers Throughout 2025
Biotricity Announces High Demand For Its LBiotres Pro, a 3-Channel Patch-like ECG, Biotres Pro Is Expected To Raise The Average Subscription Price By Over 32%, Translating To Revenue Increase Of Up To 10% From Sales To Existing Customers Throughout 2025
Biotricity宣佈對Lbiotres Pro（一種類似於貼片的三通道心電圖機）的需求旺盛，預計Biotres Pro將平均訂閱價格提高32％以上，這意味着2025年向現有客戶的銷售收入將增加多達10％
Biotres Pro Is Also Capturing The Attention Of New Customers. The Initial Production Run Of Biotres Pro Has Sold Out, With Customers Placing Pre-orders For The Next Run, Which Is Scheduled To Ship To Customers By End Of May.
Biotres Pro也吸引了新客戶的注意力。Biotres Pro的初始量產已售罄，客戶預購了下一批產品，計劃於5月底之前向客戶發貨。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。